Add electrolytes during the first two weeks
GLP-1 regulates appetite, slows digestion, and increases feelings of fullness, thereby promoting weight loss
It uniquely combines the actions of two key incretin hormonesGLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)to enhance its efficacy in weight loss
These include GLP-1R agonists [36,37,38], Type 2 sodium-glucose cotransporter (SGLT2) inhibitors (which, although associated with weight loss in people with type 2 diabetes due to their mechanism of action, are not generally considered anti-obesity drugs) [39,40,41], sympathomimetics [42, 43], serotoninergic system drugs [44,45,46], opioid receptor antagonists/weak inhibitor of neuronal dopamine and norepinephrine reuptake inhibitors [47, 48], and pancreatic lipase inhibitors [49, 50] (Fig
Vanin-1 activity is thought to counteract PPAR, as evidenced by the anti-inflammatory phenotypes of vanin-1-deficient mice that PPAR inhibitors inhibited (124)
Metformin preconditioning augments cardiac perfusion and performance in a large animal model of chronic coronary artery disease
